Table 1.
Experimental groups | Number (%) of mice with | ||||
Salmonella Typhimurium | Granulomas | ||||
ileum | blood | liver | liver | spleen | |
Gr1 (ST) | 111;2 | 3 | 113 | 164;5 | 117 |
n = 20 | 55% | 15% | 55% | 80% | 55% |
Gr2 (ST+OFX) | 21 | 1 | 3 | 86 | 07;8 |
n = 13 | 15% | 8% | 23% | 62% | |
Gr3 (ST+ME-3) | 21 | 0 | 13 | 54 | 48 |
n = 13 | 15% | 8% | 38% | 31% | |
Gr4 (ST+OFX+ME-3) | 02 | 0 | 0 | 25;6 | 07;8 |
n = 13 | 15% |
ST – Salmonella Typhimurium
OFX – ofloxacin
ME-3 – Lactobacillus fermentum ME-3
1 p = 0.032 Gr1 vs Gr2 and Gr3 viable ST in ileum
2 p = 0.002 Gr1 vs Gr4 viable ST in ileum
3 p = 0.009 Gr1 vs Gr3 viable ST in liver
4 p = 0.027 Gr1 vs Gr3 liver granulomas
5 p < 0.001 Gr1 vs Gr4 liver granulomas
6 p = 0.023 Gr2 vs Gr4 liver granulomas
7 p = 0.002 Gr1 vs Gr2 and Gr4 spleen granulomas
8 p = 0.048 Gr2 vs Gr3 and Gr4 vs Gr3 spleen granulomas